CL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Colgate-Palmolive Co is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. Despite positive analyst sentiment and strategic initiatives, the recent financial performance and technical indicators suggest caution. The stock is better suited for monitoring rather than immediate purchase.
The MACD is negative and expanding (-0.783), indicating bearish momentum. RSI is at 29.29, close to oversold territory but still neutral. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below key support levels (S1: 93.467, S2: 91.851).
Analysts have raised price targets recently, citing strong strategic initiatives and growth potential. Consumer staples are seen as a safe haven amid geopolitical tensions.
Insider selling has increased significantly (20884.53% in the last month), and the company reported a net income loss of -$37M in Q4 2025 with negative EPS (-0.05). MACD and RSI indicate bearish momentum.
In Q4 2025, revenue increased by 5.76% YoY to $5.23B. However, net income dropped by -105.01% YoY to -$37M, and EPS fell by -105.56% YoY to -0.05. Gross margin slightly declined to 60.15%.
Analysts are generally positive, with multiple firms raising price targets to $100-$105 and maintaining Buy ratings. They cite strategic initiatives, innovation, and emerging market exposure as growth drivers.
